Briacell Therapeutics Corp. (BCTX) Q2 2024 Earnings
BCTX·Reported June 14, 2024·Before market open
Diluted EPS came in at $16.49, beat the $-82.46 consensus by $98.95.
Diluted EPS
$16.49beat by $98.95
Consensus: $-82.46
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Briacell Therapeutics Corp.'s Q2 2024 earnings report.
Briacell Therapeutics Corp. (BCTX) reported Q2 2024 earnings on June 14, 2024 before market open.
Briacell Therapeutics Corp. reported diluted EPS of $16.49 for Q2 2024.
EPS beat the consensus estimate of $-82.46 by $98.95.
You can read the 10-Q periodic report (0001493152-24-023867) directly on SEC EDGAR. The filing index links above go to sec.gov.